Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
GPC3-CAR-T cells
BIOLOGICAL
2 trials
Sponsors
Beijing Tsinghua Chang Gung Hospital
, Peking University
Conditions
Hepatocellular Carcinoma
Phase 1
GPC3-CAR-T Cells for the Hepatocellular Carcinoma
Suspended
NCT04506983
Beijing Tsinghua Chang Gung Hospital
Hepatocellular Carcinoma
Start: 2022-06-10
End: 2023-10-10
Target: 12
Updated: 2022-02-14
Novel GPC3 CAR-T Cell Therapy for Hepatocellular Carcinoma
NCT05344664
Peking University
Start: 2022-04-14
End: 2025-02-01
Target: 12
Updated: 2022-04-25
Related Papers
Abstract 4006: Iterative engineering of GPC-3 targeted synthetic TCR and antigen receptor (STAR) cells in advanced solid tumors
Cancer Research
2026-04-03